Koers BELLUS Health Inc Toronto S.E.
Aandelen
CA07987C1059
Biotechnologie & Medisch Onderzoek
Omzet 2021 | 16K 11,71K 10,94K | Omzet 2022 | 16K 11,71K 10,94K | Marktkapitalisatie | 1,03 mld. 757 mln. 707 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -71 mln. -51,97 mln. -48,53 mln. | Nettowinst (verlies) 2022 | -76 mln. -55,63 mln. -51,95 mln. | EV/omzet 2021 | 36.461 x |
Nettoliquiditeiten 2021 | 248 mln. 181 mln. 169 mln. | Nettoliquiditeiten 2022 | 336 mln. 246 mln. 230 mln. | EV/omzet 2022 | 43.652 x |
K/w-verhouding 2021 |
-8,96
x | K/w-verhouding 2022 |
-12,4
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 81,52% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Roberto Bellini
CEO | Chief Executive Officer | 44 | 05-06-09 |
Jeremy Martin
PSD | President | - | - |
Chairman | 77 | 01-01-02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 77 | 01-01-02 | |
Franklin Berger
BRD | Director/Board Member | 74 | 01-05-10 |
Director/Board Member | 52 | 01-06-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,45% | 123 mld. | |
+21,96% | 115 mld. | |
+23,73% | 25,85 mld. | |
-20,05% | 20,9 mld. | |
-16,28% | 16,77 mld. | |
-16,52% | 16,52 mld. | |
-44,35% | 15,56 mld. | |
+63,91% | 15,49 mld. | |
+2,52% | 13,45 mld. |